{"schema_version":"1","generated_at":"2026-11-01T06:25:13.615Z","data_as_of":null,"url":"https://www.findmykol.com/kol/joseph-roswarski","json_url":"https://www.findmykol.com/kol/joseph-roswarski/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"joseph-roswarski","name":"Joseph Roswarski","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Georgetown University","institution_url":"https://www.findmykol.com/institution/georgetown-university","city":"Washington","state":"DC","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1215223839","orcid":"0000-0002-1470-8814","openalex":"A5029935189"},"summary":"Joseph Roswarski is an Oncology physician affiliated with Georgetown University. OpenAlex indexes 23 publications with 535 citations (h-index 9).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":23,"cited_by_count":535,"h_index":9,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":29,"program_years":{"first":2021,"last":null},"rows_total":42,"shown":3,"withheld":39,"rows":[{"payer":"Genmab U.S., Inc.","program_year":2025,"amount_usd":2241.09,"payment_count":4,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215223839"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":2173.74,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215223839"},{"payer":"BeOne Medicines USA, Inc.","program_year":2025,"amount_usd":228.46,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1215223839"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1215223839","source":"payments"},"prescribing":{"data_year":2024,"areas_total":2,"areas_shown":2,"areas":[{"area":"Cancer & immunology","share_pct":71.1,"classes_total":1,"classes":[{"class":"Kinase inhibitor","setting":"prescribed","share_pct":71.1,"drugs":[{"name":"Brukinsa","share_pct":100}],"max_beneficiaries":null}]},{"area":"Dermatology","share_pct":28.9,"classes_total":1,"classes":[{"class":"Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor","setting":"prescribed","share_pct":28.9,"drugs":[{"name":"Acyclovir","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2024,"office_pct":0,"facility_pct":100},"source":"medicare"},"publications":{"total":21,"shown":5,"withheld":16,"matched_by":"OpenAlex author record","recent":[{"title":"27 | MOSUNETUZUMAB (MOSUN) PRODUCES DURABLE BENEFIT IN PATIENTS (PTS) WITH NEWLY DIAGNOSED FOLLICULAR LYMPHOMA (FL): EXTENDED FOLLOW UP OF THE MITHIC‐FL1 TRIAL","year":2025,"journal":"Hematological Oncology","source_url":"https://doi.org/10.1002/hon.70093_27","status":"verified"},{"title":"Single-Agent Mosunetuzumab Produces High Complete Response Rates in Patients with Newly Diagnosed Follicular Lymphoma: Primary Analysis of the Mithic-FL1 Trial","year":2024,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2024-205046","status":"verified"},{"title":"Immunotherapy in the Management of Hodgkin Lymphoma: Time for Immunotherapy for All?","year":2024,"journal":"Journal of Cellular Immunology","source_url":"https://doi.org/10.33696/immunology.6.214","status":"verified"},{"title":"Fixed Duration Combination Therapy with Carfilzomib, Lenalidomide, and Dexamethasone Followed By Lenalidomide Maintenance Leads to High Rates of Sustained MRD Negativity in Patients with High-Risk Smoldering Multiple Myeloma: Long Term Follow up of an Investigator Initiated Phase 2 Trial","year":2023,"journal":"Blood","source_url":"https://doi.org/10.1182/blood-2023-181811","status":"verified"},{"title":"Severe Lenalidomide-Associated Hyperbilirubinemia","year":2023,"journal":"Cureus","source_url":"https://doi.org/10.7759/cureus.34408","status":"verified"}],"source":"works"},"contact":{"address_1":"3800 RESERVOIR RD NW","city":"Washington","state":"DC","zip":"200072113","phone":"202-444-2223","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1215223839","source":"identity"},"similar":[{"name":"Claudine Isaacs","slug":"claudine-isaacs","institution":"Georgetown University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/claudine-isaacs","json_url":"https://www.findmykol.com/kol/claudine-isaacs/profile.json"},{"name":"Jessica Ailani","slug":"jessica-ailani","institution":"Georgetown University","specialty":"Neurology","url":"https://www.findmykol.com/kol/jessica-ailani","json_url":"https://www.findmykol.com/kol/jessica-ailani/profile.json"},{"name":"Catherine Broome","slug":"catherine-broome","institution":"Georgetown University","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/catherine-broome","json_url":"https://www.findmykol.com/kol/catherine-broome/profile.json"},{"name":"Virginia Steen","slug":"virginia-steen","institution":"Georgetown University","specialty":"Rheumatology","url":"https://www.findmykol.com/kol/virginia-steen","json_url":"https://www.findmykol.com/kol/virginia-steen/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":39,"publications":16}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-09-07","provider_certified":"2022-09-07","collected_at":"2026-10-31T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}